4//SEC Filing
Miller Larry Lee 4
Accession 0001104659-21-020033
CIK 0001069899other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 8:01 PM ET
Size
9.6 KB
Accession
0001104659-21-020033
Insider Transaction Report
Form 4
Miller Larry Lee
Chief Operating Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2021-02-08+50,000→ 50,000 total - Exercise/Conversion
Restricted Stock Units
2021-02-08−250,000→ 0 total→ Class A Common Stock (250,000 underlying) - Sale
Class A Common Stock
2021-02-09$22.94/sh−20,000$458,812→ 30,000 total
Footnotes (4)
- [F1]Shares were issued in settlement of restricted stock units ("RSUs"). Each RSU represented a contingent right to receive one share of Class A Common Stock.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.59 to $23.20, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]RSUs were granted on May 7, 2018, 50,000 RSUs vested on December 31, 2020 and 200,000 performance-based RSUs were cancelled for not meeting the performance requirement. Vested shares were delivered on February 8, 2021.
Documents
Issuer
PHIBRO ANIMAL HEALTH CORP
CIK 0001069899
Entity typeother
Related Parties
1- filerCIK 0001603584
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 8:01 PM ET
- Size
- 9.6 KB